Dova Pharmaceuticals, Inc. News
Dova Pharmaceuticals to Be Bought by Swedish Orphan Biovitrum for $915M
Dova Pharmaceuticals agrees to be acquired by Swedish Orphan Biovitrum for more than $900 million.
Tuesday Investor Blog: Is the Bull Market in Stocks Being Ripped to Shreds?
Bring your A-game in these markets or go home. Just keeping it real. Here is what you need to know on Tuesday.
15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies
'Balance sheets are flush with cash and there is a need to grow for large health care companies,' Jefferies analysts wrote.
Intel Stock Tumbles After Weak Q4 Earnings, Grim Chip Sector Outlook
We stumbled ... we lost share ... we lost momentum," said CEO Pat Gelsinger.
Visa Follows Mastercard With Earnings Beat Amid Travel Spending Boom
"A continued recovery of cross-border travel," helped Visa post better-than-expected first quarter earnings.
Hasbro Stock Slumps As Toymaker Cuts Jobs, Expects Weak Holiday Revenues
"While the full-year 2022, and particularly the fourth quarter, represented a challenging moment for Hasbro, we are confident in our Blueprint 2.0 strategy," said CEO Chris Cocks.